Paper6744286
Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl rat.
van Hoesel QG and 8 others. Cancer Res, 1984. Cited by 96 papers, by iCite.
Cite this record
ConductScience Library. Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl rat. Papers, record 6744286. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6744286
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl rat.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Doxorubicin | Major topic |
| Heart | Major topic |
| Kidney | Major topic |
| Liposomes | Major topic |
| Lymphoma | Major topic |
| Animals | |
| Dose-Response Relationship, Drug | |
| Myocardium | |
| Rats | |
| Rats, Inbred Strains |
Source PubMed
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 96 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41252081 | TLD-1, a Novel Liposomal Doxorubicin, in Patients with Solid Tumors: Comparative Pharmacokinetics and Final Results of a Multicenter Phase 1 Study (SAKK 65/16). | Clin Pharmacokinet | 2026 | https://conductscience.org/library/papers/41252081 | PubMed |
| 39885941 | Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil/Caelyx): an updated analysis and future perspective. | BMJ Oncol | 2025 | https://conductscience.org/library/papers/39885941 | PubMed |
| 34219194 | Doxorubicin and doxorubicin-loaded nanoliposome induce senescence by enhancing oxidative stress, hepatotoxicity, and in vivo genotoxicity in male Wistar rats. | Naunyn Schmiedebergs Arch Pharmacol | 2021 | https://conductscience.org/library/papers/34219194 | PubMed |
| 24310494 | Nanotechnology and drug delivery: an update in oncology. | Pharmaceutics | 2011 | https://conductscience.org/library/papers/24310494 | PubMed |
| 24277284 | Stability of liposomes on storage: freeze dried, frozen or as an aqueous dispersion. | Pharm Res | 1984 | https://conductscience.org/library/papers/24277284 | PubMed |
| 22426964 | Stability influences the biodistribution, toxicity, and anti-tumor activity of doxorubicin encapsulated in PEG-PE micelles in mice. | Pharm Res | 2012 | https://conductscience.org/library/papers/22426964 | PubMed |
| 20925429 | Copper-doxorubicin as a nanoparticle cargo retains efficacy with minimal toxicity. | Mol Pharm | 2010 | https://conductscience.org/library/papers/20925429 | PubMed |
| 11718259 | High concentration of Daunorubicin and Daunorubicinol in human malignant astrocytomas after systemic administration of liposomal Daunorubicin. | J Neurooncol | 2001 | https://conductscience.org/library/papers/11718259 | PubMed |
| 8462124 | Doxorubicin and doxorubicinol pharmacokinetics and tissue concentrations following bolus injection and continuous infusion of doxorubicin in the rabbit. | Cancer Chemother Pharmacol | 1993 | https://conductscience.org/library/papers/8462124 | PubMed |
| 8269584 | Identification of vesicle properties that enhance the antitumour activity of liposomal vincristine against murine L1210 leukemia. | Cancer Chemother Pharmacol | 1993 | https://conductscience.org/library/papers/8269584 | PubMed |
| 8200855 | Improvement of therapeutic effect by using Fab' fragment in the treatment of carcinoembryonic antigen-positive human solid tumors with adriamycin-entrapped immunoliposomes. | Jpn J Cancer Res | 1994 | https://conductscience.org/library/papers/8200855 | PubMed |
| 7767956 | A two-step targeting approach for delivery of doxorubicin-loaded liposomes to tumour cells in vivo. | Cancer Chemother Pharmacol | 1995 | https://conductscience.org/library/papers/7767956 | PubMed |
| 7642689 | Doxorubicin-heparin complex: reduction of cardiotoxicity of doxorubicin. | J Cancer Res Clin Oncol | 1995 | https://conductscience.org/library/papers/7642689 | PubMed |
| 7506649 | Liposomes as carriers of cancer chemotherapy. Current status and future prospects. | Drugs | 1993 | https://conductscience.org/library/papers/7506649 | PubMed |
| 3520474 | Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties. | Pharm Weekbl Sci | 1986 | https://conductscience.org/library/papers/3520474 | PubMed |
| 3413128 | Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. | Proc Natl Acad Sci U S A | 1988 | https://conductscience.org/library/papers/3413128 | PubMed |
| 3370737 | Liposomes as drug carrier system for cis-diamminedichloroplatinum (II). II. Antitumor activity in vivo, induction of drug resistance, nephrotoxicity and Pt distribution. | Cancer Chemother Pharmacol | 1988 | https://conductscience.org/library/papers/3370737 | PubMed |
| 3042244 | Clinical pharmacokinetics of doxorubicin. | Clin Pharmacokinet | 1988 | https://conductscience.org/library/papers/3042244 | PubMed |
| 2965295 | Liposomes in chemo- and immunotherapy of cancer. | Lipids | 1987 | https://conductscience.org/library/papers/2965295 | PubMed |
| 2791187 | A comparative study on the antitumor effect, cardiotoxicity and nephrotoxicity of doxorubicin given as a bolus, continuous infusion or entrapped in liposomes in the Lou/M Wsl rat. | Cancer Chemother Pharmacol | 1989 | https://conductscience.org/library/papers/2791187 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6744286
GET https://conductscience.org/api/papers/v1/6744286/cited_by?page=2